TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33687463

Group type: EXPERIMENTAL
Intervention: Ventral surgery
Number of subjects: 163

Group type: COMPARATOR
Intervention: Dorsal surgery
Number of subjects: 163
Study: 34100922

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Apremilast 20 mg
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study: 32623947

Group type: EXPERIMENTAL
Intervention: Responsive group (n = 45)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Mildly responsive group (n = 109)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Mildly non-responsive group (n = 90)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Strongly non-responsive group (n = 21)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Responsive groups vs Non-responsive groups
Number of subjects: 265

Group type: COMPARATOR
Intervention: Mildly non-responsive group vs Strongly non-responsive group
Number of subjects: 265
Study: 36334963

Group type: EXPERIMENTAL
Intervention: Conferoport (generic ER-Tac)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Advagraf (reference brand ER-Tac)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 52
Study: 32333486

Group type: EXPERIMENTAL
Intervention: Acceptance-based group behavioral therapy (ABBT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard nondirective supportive group therapy (NDST)
Number of subjects: 92
Study: 35524376

Group type: EXPERIMENTAL
Intervention: Krocina™
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32937273

Group type: EXPERIMENTAL
Intervention: Ankle bandaging
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ankle taping
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (placebo taping)
Number of subjects: 100
Study: 36889873

Group type: EXPERIMENTAL
Intervention: Daily remote monitoring data
Number of subjects: 2718

Group type: EXPERIMENTAL
Intervention: Neural network modeling
Number of subjects: 2718
Study: 32383227

Group type: EXPERIMENTAL
Intervention: Oral Nicotinamide (NAM) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35970102

Group type: EXPERIMENTAL
Intervention: FOLFOX plus panitumumab
Number of subjects: 106

Group type: COMPARATOR
Intervention: FOLFOX (control)
Number of subjects: 106
Study: 34386892

Group type: EXPERIMENTAL
Intervention: FemoSeal® (FS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: ProGlide® (PG)
Number of subjects: 230
Study: 34562564

Group type: EXPERIMENTAL
Intervention: Low-dose Guizhi Fuling Wan
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Conventional-dose Guizhi Fuling Wan
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sub-effective dose control (not explicitly named)
Number of subjects: 78
Study: 32986364

Group type: EXPERIMENTAL
Intervention: Smoke-Free Policy (SFP) compliance criteria
Number of subjects: 105
Study: 36375708

Group type: EXPERIMENTAL
Intervention: Ozonated water (OZW) mouthwash
Number of subjects: 73

Group type: COMPARATOR
Intervention: Chlorhexidine (CHG) mouthwash
Number of subjects: 73
Study: 33399376

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (Deep NMB)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (Mod NMB)
Number of subjects: 82
Study: 32739846

Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Number of subjects: 136

Group type: COMPARATOR
Intervention: Topical piroxicam
Number of subjects: 136
Study: 36082065

Group type: EXPERIMENTAL
Intervention: ERAS concept combined with self‐made raising leg pad nursing
Number of subjects: 98

Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 98
Study: 32845223

Group type: EXPERIMENTAL
Intervention: Endoscopic staplers (n = 26)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Vessel sealing device (Ligasure) (n = 25)
Number of subjects: 51
Study: 32106339

Group type: EXPERIMENTAL
Intervention: DS-1040 with multiple-dose aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DS-1040 with multiple-dose clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DS-1040 with single-dose enoxaparin
Number of subjects: 0
Study: 35688920

Group type: EXPERIMENTAL
Intervention: Estimation formula for tourniquet pressure (TP) based on thigh circumferences and systolic blood pressure (SBP)
Number of subjects: 3

Group type: COMPARATOR
Intervention: SBP plus 100 mmHg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Fixed value of 300 mmHg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Estimation method for TP
Number of subjects: 3
Study: 34434003

Group type: EXPERIMENTAL
Intervention: BMAC injection followed by PRP injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gel-One® cross-linked hyaluronate (HA) injection
Number of subjects: 0
Study: 32445557

Group type: EXPERIMENTAL
Intervention: MG+SG (compression with foam roller/ball + static stretching)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MG (compression only)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SG (static stretching only)
Number of subjects: 80

Group type: COMPARATOR
Intervention: CG (control group, no intervention)
Number of subjects: 80
Study: 35958675

Group type: EXPERIMENTAL
Intervention: Patellar taping and EMG‐BF‐guided isometric contraction exercise at 30°, 60°, and 90° angles
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham patellar taping without EMG‐BF‐guided exercises
Number of subjects: 60
Study: 33763732

Group type: EXPERIMENTAL
Intervention: MSON (ON-affected eyes of MS patients)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MSNON (fellow healthy eyes of MS patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MSON
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MSNON
Number of subjects: 20
Study: 32883279

Group type: EXPERIMENTAL
Intervention: Peer-support lifestyle intervention (12-month duration, 15 group sessions in community settings)
Number of subjects: 1007

Group type: COMPARATOR
Intervention: Control group received a booklet on lifestyle change
Number of subjects: 1007
Study: 35049354

Group type: EXPERIMENTAL
Intervention: Automated insulin delivery (AID)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP)
Number of subjects: 14
Study: 33784580

Group type: EXPERIMENTAL
Intervention: Multidisciplinary simulation team training
Number of subjects: 10
Study: 34924557

Group type: EXPERIMENTAL
Intervention: Telephone-based lifestyle weight loss intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 280
Study: 33167568

Group type: EXPERIMENTAL
Intervention: Whole genome sequencing of porcine astroviruses from piglets
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Recombination analysis of PoAstV4
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Linear antigen epitope prediction and comparative analysis of capsid protein
Number of subjects: 446
Study: 34981778

Group type: EXPERIMENTAL
Intervention: Sustained oral peanut protein exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cessation of peanut consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of HLA-DQA1*01:02
Number of subjects: 0

Group type: COMPARATOR
Intervention: Absence of oral peanut protein exposure
Number of subjects: 0
Study: 32666822

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) for 6 months
Number of subjects: 0
Study: 33476409

Group type: EXPERIMENTAL
Intervention: HIMV (high intended movement velocity)
Number of subjects: 20

Group type: COMPARATOR
Intervention: TRAD (traditional training)
Number of subjects: 20
Study: 32912546

Group type: EXPERIMENTAL
Intervention: Levetiracetam for seven days post-operatively
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard care alone (no levetiracetam)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study: 34924372

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei releasing Ang-(1-7) (LP-A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 0
Study: 33073963

Group type: EXPERIMENTAL
Intervention: Pregnant patients with metabolic syndrome (MS)
Number of subjects: 62
Study: 35671671

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 32669487

Group type: COMPARATOR
Intervention: Stretch group (hip muscle stretching exercises)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Strengthen group (hip muscle strengthening exercises)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sham group (gentle palpation of the skin)
Number of subjects: 66
Study: 34425223

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 35022147

Group type: EXPERIMENTAL
Intervention: Negative‐Pressure Wound Therapy (NPWT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wet‐to‐dry dressing
Number of subjects: 30
Study: 36137919

Group type: EXPERIMENTAL
Intervention: Orthokeratology lens wear
Number of subjects: 50
Study: 32969513

Group type: EXPERIMENTAL
Intervention: Laplace-based algorithm for treatment allocation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiarmed bandit approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized N-of-1 trial design
Number of subjects: 0
Study: 34249850

Group type: EXPERIMENTAL
Intervention: Digital or face-to-face alcohol prevention intervention
Number of subjects: 779

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Willing employees
Number of subjects: 779
Study: 32035020

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus capivasertib (400 mg orally twice daily on an intermittent weekly schedule)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Fulvestrant plus placebo
Number of subjects: 140
Study: 35797557

Group type: EXPERIMENTAL
Intervention: Acellular fish skin graft
Number of subjects: 94

Group type: COMPARATOR
Intervention: Collagen alginate dressing
Number of subjects: 94
Study: 33798304

Group type: EXPERIMENTAL
Intervention: Bushen Tiaodu Yizhi acupuncture combined with computer‐assisted cognitive training
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional treatment with acupuncture at acupoints of limbs
Number of subjects: 98
Study: 32609022

Group type: EXPERIMENTAL
Intervention: 2% zinc sulfate
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: vitamin D3
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Candida antigen
Number of subjects: 152

Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 152
Study: 34237262

Group type: EXPERIMENTAL
Intervention: BCG revaccination
Number of subjects: 46889

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46889
Study: 32446145

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 758

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 758
Study: 36190011

Group type: EXPERIMENTAL
Intervention: Dapagliflozin, 10 mg, once daily
Number of subjects: 6263
Study: 33989711

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 777

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 777
Study: 33274895

Group type: EXPERIMENTAL
Intervention: Foliar application of algae at 8 g L‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foliar application of yeast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control treatment (foliar water)
Number of subjects: 0
Study: 34412973

Group type: EXPERIMENTAL
Intervention: HCG (500 IU in 0.1 ml of tissue culture media)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Culture media (0.1 ml of tissue culture media)
Number of subjects: 181
Study: 33028361

Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum infection
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Mild anaemia in P. falciparum-infected children
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Underweight
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Residence near water collections
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Total white blood cells, monocytes, and platelets
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 400
Study: 33400432

Group type: EXPERIMENTAL
Intervention: High-voltage PRF combined with low-temperature CRF (70 V, 42°C, 2 Hz, pulse width 20 ms, treatment time 600 s; CRF at 60°C, treatment time 270 s)
Number of subjects: 146

Group type: COMPARATOR
Intervention: High-voltage PRF only (70 V, 42°C, 2 Hz, pulse width 20 ms, treatment time 600 s)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: High-voltage PRF combined with low-temperature CRF
Number of subjects: 146

Group type: COMPARATOR
Intervention: High-voltage PRF only
Number of subjects: 146
Study: 32277977

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT, n=149, 3/wk)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Resistance Training (MIT, n=154, 3/wk)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Non-exercise activities (CON, n=148)
Number of subjects: 451
Study: 35658942

Group type: EXPERIMENTAL
Intervention: Unguided iCBT
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Guided iCBT
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 1500
Study: 32538008

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) applied at specific acupoints on days 1, 2, 3, 5, 8, 14, 21, and 28 of chemotherapy, 30 minutes each time, once a day.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Medication group received DiyuShengbai tablets before chemotherapy, 2-3 tablets each time, 3 times a day.
Number of subjects: 102

Group type: COMPARATOR
Intervention: TEAS group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional group (chemotherapy with gemcitabine and cisplatin plus routine care)
Number of subjects: 102
Study: 35980949

Group type: EXPERIMENTAL
Intervention: EGFR mutation
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: HER2 mutation
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: BRAF mutation
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Fusion mutation (ALK and ROS1)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: KRAS mutation
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Non-adenocarcinoma histology
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: ROS-1 rearranged patients with strong PD-L1 expression
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: KRAS-mutant patients with strong PD-L1 expression
Number of subjects: 1001
Study: 33189857

Group type: EXPERIMENTAL
Intervention: tDCS with sham MCAT treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MCAT with sham tDCS
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined tDCS and MCAT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham tDCS and sham MCAT
Number of subjects: 100
Study: 35254460

Group type: EXPERIMENTAL
Intervention: Group 1: Two parallel longitudinal screws and two screws fixing the intraarticular posterior facet fracture line
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group 2: Two screws entered the tuberosity inferiorly to the Achilles tendon insertion and two transverse screws fixed the posterior facet
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group 3: Two screws inserted along the bone axis, one transverse screw fixed the posterior facet and one oblique screw inserted from the posteroplantar part of the tuberosity
Number of subjects: 15
Study: 34678874

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 272

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 272
Study: 34475178

Group type: EXPERIMENTAL
Intervention: CDTI plus annual SC for 2 years
Number of subjects: 8

Group type: COMPARATOR
Intervention: CDTI only for two consecutive years
Number of subjects: 8
Study: 35787211

Group type: EXPERIMENTAL
Intervention: FiberStich (knotless soft anchoring)
Number of subjects: 60

Group type: COMPARATOR
Intervention: IO-S (inside-out suture repair)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IO-ST (inside-out suture tape)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FastFix 360
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Stryker AIR
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TrueSpan
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FiberStich
Number of subjects: 60
Study: 33419698

Group type: EXPERIMENTAL
Intervention: Vibration guidance CPR
Number of subjects: 130

Group type: COMPARATOR
Intervention: Metronome guidance CPR
Number of subjects: 130
Study: 32571263

Group type: EXPERIMENTAL
Intervention: Individuals self-identifying as having or having had a prescription drug abuse issue
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Male respondents
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Older respondents (55+)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Male and younger respondents
Number of subjects: 631
Study: 36336989

Group type: EXPERIMENTAL
Intervention: Ciclopirox nail hydrolacquer
Number of subjects: 381

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 381

Group type: COMPARATOR
Intervention: Reference product (hydroxypropyl chitosan‐based 80 mg/g ciclopirox nail lacquer)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 381
Study: 33567047

Group type: EXPERIMENTAL
Intervention: NPWT + PRP gel
Number of subjects: 102

Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 102
Study: 32303260

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy program (10 two-hour weekly sessions)
Number of subjects: 24
Study: 35544074

Group type: EXPERIMENTAL
Intervention: 3BNC117 plus romidepsin
Number of subjects: 22

Group type: COMPARATOR
Intervention: romidepsin
Number of subjects: 22
Study: 33861679

Group type: EXPERIMENTAL
Intervention: Sabin inactivated poliovirus vaccine (sIPV)
Number of subjects: 250
Study: 35180260

Group type: EXPERIMENTAL
Intervention: Clown visits by RED NOSES Clowndoctors Austria on a weekly basis over four consecutive weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Clown visits
Number of subjects: 50
Study: 33407263

Group type: EXPERIMENTAL
Intervention: Continued annual mass azithromycin distribution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stopping annual azithromycin distribution
Number of subjects: 0
Study: 32542869

Group type: EXPERIMENTAL
Intervention: Transepidermal application of CO2 (twice daily for 1 week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Formulation containing hydrochloric acid (control)
Number of subjects: 20
Study: 36454865

Group type: EXPERIMENTAL
Intervention: Self-assessed push-up test via ecofit app
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Self-assessed sit-to-stand test via ecofit app
Number of subjects: 54
Study: 32833584

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normothermia (later comparison)
Number of subjects: 20
Study: 35871338

Group type: EXPERIMENTAL
Intervention: Multimodal exercise program with omega-3 (900 mg EPA, 600 mg DHA), vitamin D (1000 IU), and protein (20 g) supplement (n=73)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control condition with stretching/flexibility sessions and placebo (n=74)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Multimodal exercise program with omega-3, vitamin D, and protein supplement (n=73)
Number of subjects: 147
Study: 33549192

Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 4 weeks
Number of subjects: 435

Group type: COMPARATOR
Intervention: Placebo every 4 weeks
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 8 weeks
Number of subjects: 435

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 435
Study: 33407609

Group type: EXPERIMENTAL
Intervention: Tomato sauce (OsteoCol) 150 ml/day
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sterol-enriched yogurt (1.6 g/die)
Number of subjects: 108
Study: 35125237

Group type: EXPERIMENTAL
Intervention: Acu-TENS (transcutaneous electrical acupoint stimulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham Acu-TENS
Number of subjects: 40
Study: 34672147

Group type: EXPERIMENTAL
Intervention: Moderate work rate (30 W/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low work rate (10 W/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High work rate (60 W/min)
Number of subjects: 12
Study: 32159711

Group type: EXPERIMENTAL
Intervention: Treatment as usual plus immediate access to Deprexis
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment as usual plus delayed access to Deprexis (after 8 weeks)
Number of subjects: 128
Study: 35103537

Group type: EXPERIMENTAL
Intervention: DBT plus DM
Number of subjects: 26877

Group type: COMPARATOR
Intervention: DM
Number of subjects: 26877
Study: 34471452

Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as usual (boxing/martial arts)
Number of subjects: 30
Study: 36128636

Group type: EXPERIMENTAL
Intervention: Add-on PEG-IFN
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Switch to PEG-IFN
Number of subjects: 153

Group type: COMPARATOR
Intervention: Continuous entecavir monotherapy
Number of subjects: 153
Study: 33278364

Group type: EXPERIMENTAL
Intervention: Perturbation-based pinch task training (20 minutes per session, twice a week for 6 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Task-specific motor training (20 minutes per session, twice a week for 6 weeks)
Number of subjects: 19